<DOC>
	<DOCNO>NCT01316458</DOCNO>
	<brief_summary>To investigate ability 600 mg GlivecÂ® , give daily mouth patient rise PSA follow radical prostatectomy , produce sustained biochemical response first 6 month treatment .</brief_summary>
	<brief_title>Glivec Prostate Cancer Patients With Rising PSA Following Radical Prostectomy</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Urogenital Neoplasms</mesh_term>
	<mesh_term>Prostatic Diseases</mesh_term>
	<mesh_term>Genital Neoplasms , Male</mesh_term>
	<mesh_term>Genital Diseases , Male</mesh_term>
	<mesh_term>Abdominal Neoplasms</mesh_term>
	<mesh_term>Imatinib Mesylate</mesh_term>
	<criteria>18 year age old . undergone radical prostatectomy within 2 year prior PSA progression . exhibit two consecutive rise PSA level relative previous reference value , separate 14 day . The first measurement must occur 14 day reference value und must least 20 % reference value . The reference value must least 0.4 ng/ml . The second confirmatory measurement take 14 day first measurement must great first measurement . Karnofsky Performance Score ( KPS ) great equal 90 ( Appendix 5 ) . follow hematologic lab value : ANC great equal 1500/mm3 , Hgb great equal 10g/dL , PLT great equal 100x109/L . follow biochemistry lab value : total bilirubin &lt; 1.5 ULN , SGOT , SGPT le equal 2.5 ULN , serum creatinine less equal 1.5 ULN . willing employ effective barrier method contraception study duration 3 month follow discontinuation study drug ( patient reproductive potential ) . life expectancy &gt; 6 month . provide write informed consent pursuant local regulatory requirement prior initiation study procedure . Gleason Score &gt; 6 prostatectomy specimen history another malignancy within 5 year prior study entry , except curatively treat nonmelanotic skin cancer , unless write approval obtain sponsor . prior hormonal therapy require therapy warfarin analgesic morphine class high ( see Section 3.4.4 ) . know diagnosis HIV , hepatitis B , hepatitis C infection . major surgery within 2 week prior study entry . severe , unstable , uncontrolled medical disease would confound diagnosis evaluation require protocol , include severe cardiac insufficiency ( NYHA III IV , see Appendix 2 ) , uncontrolled diabetes , chronic hepatic renal disease , active uncontrolled infection . history noncompliance medical regimen inability unwillingness return schedule visit . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Prostate cancer ,</keyword>
	<keyword>radical prostatectomy ,</keyword>
	<keyword>PSA rise</keyword>
</DOC>